Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Slides:

Advertisements

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Advertisements

Tomislav Mihaljevic, MD, Edward R

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine

Characterization and Importance of Air Leak After Lobectomy

A. Marc Gillinov, MD, Tomislav Mihaljevic, MD, Eugene H

Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis Syed T. Hussain, MD, Nabin K. Shrestha, MD, Steven.

Generating New Knowledge in Cardiac Interventions

Surgical management of secondary tricuspid valve regurgitation: Annulus, commissure, or leaflet procedure? Jose L. Navia, MD, Edward R. Nowicki, MD,

Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status.

Advising complex patients who require complex heart operations

Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H

Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both? Alessandro Vivacqua, MD, Colleen G. Koch, MD,

Effect of changes in postoperative spirometry on survival after lung transplantation David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,

Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy Nicholas G. Smedira, MD, Bruce W. Lytle, MD,

Beyond the Aortic Root: Staged Open and Endovascular Repair of Arch and Descending Aorta in Patients With Connective Tissue Disorders Eric E. Roselli,

Robert J. Steffen, MD, Eugene H. Blackstone, MD, Nicholas G

Mitral Valve Surgery in the Adult Marfan Syndrome Patient

Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysm

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Reoperation After Mitral Valve Repair for Degenerative Disease

Bruce W. Lytle, MD, Eugene H. Blackstone, MD, Joseph F

Jonathan W. Cramer, MD, Salil Ginde, MD, Garick D. Hill, MD, Scott B

Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization Suresh Keshavamurthy, MBBS, MS, Colleen.

Coronary artery bypass grafting in diabetics: A growing health care cost crisis Sajjad Raza, MD, Joseph F. Sabik, MD, Ponnuthurai Ainkaran, MS, Eugene.

Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair Douglas R. Johnston, MD, A. Marc Gillinov, MD,

Benefits of Early Surgery on Clinical Outcomes After Degenerative Mitral Valve Repair Tianyu Zhou, MD, Jun Li, MD, PhD, Hao Lai, MD, PhD, Kai Zhu, MD,

Lu Dai, MSc, Stephanie L. Mick, MD, Keith R. McCrae, MD, Penny L

Tricuspid valve repair: durability and risk factors for failure

Effects of right ventricular morphology and function on outcomes of patients with degenerative mitral valve disease Ying Ye, BS, Ravi Desai, MD, Lina.

Too High for Transplantation

Aggressive Patch Augmentation May Reduce Growth Potential of Hypoplastic Branch Pulmonary Arteries After Tetralogy of Fallot Repair Travis J. Wilder,

Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine

Simple versus complex degenerative mitral valve disease

A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R

Ahmad Zeeshan, MD, Jay J. Idrees, MD, Douglas R

Tricuspid Regurgitation Associated With Ischemic Mitral Regurgitation: Characterization, Evolution After Mitral Surgery, and Value of Tricuspid Repair

Travis J. Wilder, MD, Brian W. McCrindle, MD, Edward J

A “Repair-All” Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement Andrew B. Goldstone, MD, Jeffrey E. Cohen, MD,

Robert J. Moraca, MD, Marc R. Moon, MD, Jennifer S

Long-Term Durability of Bicuspid Aortic Valve Repair

Farhang Yazdchi, MD, MS, Colleen G

Vinod H. Thourani, MD, Hanna A

del Nido versus Buckberg cardioplegia in adult isolated valve surgery

Outcomes of less invasive J-incision approach to aortic valve surgery

Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L

Minimally Invasive Fibrillating Heart Surgery: A Safe and Effective Approach for Mitral Valve and Surgical Ablation for Atrial Fibrillation Paul S. Massimiano,

Reintervention After Heller Myotomy for Achalasia: Is It Inevitable?

Lars G. Svensson, MD, PhD, Gregory D

Outcomes of a Less-Invasive Approach for Proximal Aortic Operations

Comparative study of bronchial artery revascularization in lung transplantation Gösta B. Pettersson, MD, PhD, Karam Karam, MD, Lucy Thuita, MS, Douglas.

Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings Sunil K Bhudia, MD, Patrick M McCarthy, MD, Nicholas G Smedira, MD, Buu-Khanh.

Primary Cardiac Sarcoma

David P. Mason, MD, Dale H. Marsh, MD, Joan M. Alster, MS, Sudish C

Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes Ryan K. Kaple, BS, Ross T. Murphy, MD, Linda.

Lars G. Svensson, MD, PhD, Fernando A. Atik, MD, Delos M

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Mohammed A Quader, MD, Patrick M McCarthy, MD, A

Is repair preferable to replacement for ischemic mitral regurgitation?

John M. Stulak, MD, Rakesh M. Suri, MD, DPhil, Joseph A

Douglas R. Johnston, MD, Edward G

Turki B. Albacker, MD, MSc, Eugene H. Blackstone, MD, Sarah J

Mitral valve repair with aortic valve replacement is superior to double valve replacement A.Marc Gillinov, MD, Eugene H Blackstone, MD, Delos M Cosgrove,

Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: Implications for transcatheter aortic valve replacement

Mitral Repair Versus Replacement for Ischemic Mitral Regurgitation

Hemodynamic stability during 17 years of the carpentier-edwards aortic pericardial bioprosthesis Michael K Banbury, MD, Delos M Cosgrove, MD, James D.

Lung Transplantation for Idiopathic Pulmonary Fibrosis

International Normalized Ratio Self-Management Lowers the Risk of Thromboembolic Events After Prosthetic Heart Valve Replacement Thomas Eitz, MD, Soren.

Fernando A. Atik, MD, Lars G. Svensson, MD, PhD, FACC, Eugene H

Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W

Presentation transcript:

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi, MD, Allan L. Klein, MD, Lee Fong Ling, MBBS, Chanapong Kittayarak, MD, Edward R. Nowicki, MD, MS, Lillian H. Batizy, MS, Jiansheng Zhong, MS, Eugene H. Blackstone, MD The Annals of Thoracic Surgery Volume 93, Issue 1, Pages 59-69 (January 2012) DOI: 10.1016/j.athoracsur.2011.08.037 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Propensity score distribution and results of propensity score matching. (A) Mirrored histogram of distribution of propensity scores. No tricuspid valve (TV) repair group appears above the horizontal line of zero and tricuspid valve repair group below it. Dark bars indicate distribution of propensity scores of matched patients. (B) Covariate balance for selected variables before matching (filled triangles) and after matching (filled squares). Values on the horizontal axis represent the percent standardized difference [1] between tricuspid valve repair and no-repair groups. Data from Austin and Mamdani [29]. (AV = atrial valve; MV = mitral valve; RV = right ventricular.) The Annals of Thoracic Surgery 2012 93, 59-69DOI: (10.1016/j.athoracsur.2011.08.037) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Bubble plot of predischarge grade of tricuspid regurgitation (TR) compared with preoperative level 2+ among propensity-matched patients stratified by undergoing tricuspid valve (TV) repair or not. The Annals of Thoracic Surgery 2012 93, 59-69DOI: (10.1016/j.athoracsur.2011.08.037) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Percent of propensity-matched patients in each grade of tricuspid valve (TV) regurgitation (TR) postoperatively: (A) TR 0; (B) TR 1+; (C) TR 2+; (D) TR 3+/4+. Horizontal lines are point estimates enclosed within dashed 68% confidence bands. These have been adjusted for repeated measures. Symbols represent data grouped (without regard to repeated measurements) within time frames to provide a crude verification of model fit. The Annals of Thoracic Surgery 2012 93, 59-69DOI: (10.1016/j.athoracsur.2011.08.037) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Percent of propensity-matched patients in each New York Heart Association (NYHA) functional class, depicted from operation to 6 years postoperatively: (A) NYHA class I; (B) NYHA class II; (C) NYHA class III; (D) NYHA class IV (depiction is as in Figure 3). (TR = tricuspid regurgitation; TV = tricuspid valve.) The Annals of Thoracic Surgery 2012 93, 59-69DOI: (10.1016/j.athoracsur.2011.08.037) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Survival of propensity-matched patients with or without a tricuspid valve (TV) repair. Each symbol represents a death, vertical bars 68% confidence limits, and numbers in parentheses patients remaining at risk. Solid lines enclosed within dashed 68% confidence bands are parametric survival estimates. The Annals of Thoracic Surgery 2012 93, 59-69DOI: (10.1016/j.athoracsur.2011.08.037) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions